← Leaderboards
Kimberly Briggs
Dana-Farber Cancer Inst
$125,108
Attributed
$125,108
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $55.7K · FY2011–13$100K$75K$50K$25K$0
'11
'12
'13
Funding mix
By agency
NIH$125,108 · 1
By mechanism
F32$125,108 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kornelia Polyak$28,582,691
- Piotr Sicinski$42,703,610
- Donald W. Kufe$50,160,456
- Tracy T Batchelor$27,819,477
- Alan David D'andrea$28,094,196
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAlpha KetoglutarateBaseBreast Cancer CellCancer Cell LineCancer TherapyCell ProliferationClinicDiagnosisEffective TherapyErbb2 GeneEstrogen ReceptorsEstrogensGenesGene TargetingHormonalHypoxia Inducible Factor 1In VitroIn VivoLeadMalignant Breast NeoplasmMalignant NeoplasmsMammary TumorigenesisMolecular
Grant awards (3)
The role of HIF1a in the tumorigenesis of triple-negative breast cancer$16,396
F32 · FY2013 · CA · contact PI
The role of HIF1a in the tumorigenesis of triple-negative breast cancer$55,670
F32 · FY2012 · CA · contact PI
The role of HIF1a in the tumorigenesis of triple-negative breast cancer$53,042
F32 · FY2011 · CA · contact PI